Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_assertion type Assertion NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_head.
- NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_assertion wasGeneratedBy ECO_0000203 NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_provenance.
- NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_assertion wasDerivedFrom befree-2016 NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_provenance.
- NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_assertion SIO_000772 24124571 NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_provenance.
- NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_assertion evidence source_evidence_literature NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_provenance.
- NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_assertion description "[Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1119103.RAKquGxLYG7fghVyQBhZ485GEjixXX1L6MBKsQyj9Gc-A130_provenance.